Transparency, Imaginary Worlds and ICER Value Assessments
The Institute for Clinical and Economic Review (ICER) is seen as offering a credible platform for evaluating the pricing policies for pharmaceutical products and devices. Over the past few years ICER has presented a stream of reports, many of which have recommended substantial price discounts where...
Saved in:
Main Author: | Paul C. Langley (Author) |
---|---|
Format: | Book |
Published: |
University of Minnesota Libraries Publishing,
2017-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ICER, ISPOR AND QALYs: A Tale of Imaginary Worlds
by: Paul Langley
Published: (2019) -
Nonsense on Stilts - Part 1: The ICER 2020-2023 Value Assessment Framework for Constructing Imaginary Worlds
by: Paul Langley
Published: (2020) -
CVS Health and the Imaginary Worlds of the Institute for Clinical and Economic Review (ICER)
by: Paul Langley
Published: (2018) -
Alternative Facts and the ICER Proposed Policy on Access to Imaginary Pharmacoeconomic Worlds
by: Paul Langley
Published: (2018) -
Another Rush to Judgement: The Imaginary Worlds of ICER and Recommendations in Duchenne Muscular Dystrophy
by: Paul Langley
Published: (2019)